Cargando…
Tolerance induction with donor hematopoietic stem cell infusion in kidney transplantation: a single-center experience in China with a 10-year follow-up
BACKGROUND: Immunosuppressive therapy after life-saving kidney transplantation increases the risk of infection, cardiovascular diseases, metabolic diseases, and cancer. To date, four centers (three in the USA and one in South Korea) have reported clinical tolerance trials in kidney transplantation....
Autores principales: | Wang, Xuanchuan, Yang, Cheng, Hu, Linkun, Wei, Zheng, Tang, Qunye, Chen, Bing, Ji, Yuan, Xu, Ming, Zeng, Zhaochong, Rong, Ruiming, Zhu, Tongyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723571/ https://www.ncbi.nlm.nih.gov/pubmed/33313123 http://dx.doi.org/10.21037/atm-20-2502a |
Ejemplares similares
-
Hematopoietic stem cell transplantation induces immunologic tolerance in renal transplant patients via modulation of inflammatory and repair processes
por: Wu, Duojiao, et al.
Publicado: (2012) -
In utero hematopoietic cell transplantation: induction of donor specific immune tolerance and postnatal transplants
por: Peranteau, William H.
Publicado: (2014) -
Basiliximab for the therapy of acute T cell–mediated rejection in kidney transplant recipient with BK virus infection: A case report
por: Chen, Tingting, et al.
Publicado: (2022) -
Bioinformatics analyses on the immune status of renal transplant patients, a systemic research of renal transplantation
por: Meng, Mei, et al.
Publicado: (2020) -
Donor Lymphocyte Infusion and Molecular Monitoring for Relapsed Myelofibrosis After Hematopoietic Cell Transplantation
por: Gagelmann, Nico, et al.
Publicado: (2023)